• About us
• Contact

Advertisement

Product › Details

cancer test

	Next higher product group	clinical test (diagnostic test for human use)

Record changed: 2024-02-26

Advertisement

More documents for cancer test

• [1] Mainz Biomed N.V.. (11/12/24). "Press Release: Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets". Berkeley, CA & Mainz....
• [2] Agilent Technologies Inc.. (9/12/23). "Press Release: Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience". Santa Clara, CA & Madison, WI....
• [3] Thermo Fisher Scientific Inc.. (10/31/22). "Press Release: Thermo Fisher Scientific to Acquire The Binding Site Group". Waltham, MA....
• [4] NeoGenomics, Inc.. (5/9/22). "Press Release: NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary". Ft. Myers, FL....
• [5] Inivata Ltd.. (4/28/21). "Press Release: Inivata and Agendia Sign Agreement for Commercialization of RaDaR MRD Liquid Biopsy Assay in Breast Cancer". Research Triangle Park, NC, Cambridge, Irvine, CA & Amsterdam....
• [6] Agilent Technologies Inc.. (4/15/21). "Press Release: Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology". Santa Clara, CA....
• [7] Inivata Ltd.. (3/9/21). "Press Release: FDA Grants Breakthrough Device Designation for Inivata’s RaDaR Assay". Research Triangle Park, NC & Cambridge....
• [8] Agilent Technologies Inc.. (3/2/21). "Press Release: Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics". Santa Clara, CA....
• [9] Inivata Ltd.. (2/4/21). "Press Release: Inivata Raises $35 million in Second Close of Series C Financing". Research Triangle Park, NC & Cambridge....
• [10] Sebia S.A.. (12/9/20). "Press Release: Sebia Enters into License Agreement with Erasmus MC and Radboudumc to Provide Minimal Residual Disease Test from Serum Samples of Multiple Myeloma Patients". Paris....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.